Generic dry powder inhalers bioequivalence: Batch–to-batch variability insights

R Salama, HJ Choi, J Almazi, D Traini, P Young - Drug Discovery Today, 2022 - Elsevier
Highlights•Batch-to-batch bioinequivalence has negligible clinical downsides.•Choice of
Reference batch for generic bioequivalence testing is significant.•To date, different …

Novel nanocrystal injection of insoluble drug anlotinib and its antitumor effects on hepatocellular carcinoma

M Luo, H Sun, Q Jiang, Y Chai, C Li, B Yang… - Frontiers in …, 2021 - frontiersin.org
The molecularly targeted agent anlotinib offers a novel therapeutic strategy against
advanced hepatocellular carcinoma (HCC). With this study, we aimed to solve the technical …

Progress Towards the Integration of Experimental and Computational Techniques to Better Understand the Delivered Dose of Aerosolised Medication

NVE Anderson - 2024 - espace.curtin.edu.au
A significant gap exists in our knowledge of how to deliver inhaled medicines effectively and
safely to children and adolescents, and off-label respiratory drug use is common in …

Systems-based Approach to Design and Optimization of Treatment for Pulmonary Infections: Strategy to Combat Antimicrobial Resistance

SB Yeshwante - 2024 - search.proquest.com
Abstract The World Health Organization has identified antimicrobial resistance (AMR)
among the top five greatest threats to human health. Due to lack of novel therapies and …